Yahoo
NasdaqCM - Delayed Quote USD

IM Cannabis Corp. (IMCC)

1.9800 -0.2200 (-10.00%)
At close: September 4 at 4:00:00 PM EDT
1.9700 -0.0100 (-0.51%)
After hours: September 4 at 7:30:02 PM EDT
Chart Range Bar
Loading chart for IMCC
  • Previous Close 2.2000
  • Open 2.3700
  • Bid 0.1033 x 200
  • Ask 2.2700 x 100
  • Day's Range 1.9500 - 2.3700
  • 52 Week Range 1.9500 - 77.1000
  • Volume 91,280
  • Avg. Volume 206,890
  • Market Cap (intraday) 1.196M
  • Beta (5Y Monthly) 2.10
  • PE Ratio (TTM) --
  • EPS (TTM) -76.0500
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.

imcannabis.com

44

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IMCC
95.25%
S&P 500 (^GSPC)
12.75%

1-Year Return

IMCC
96.78%
S&P 500 (^GSPC)
18.71%

3-Year Return

IMCC
98.68%
S&P 500 (^GSPC)
70.93%

5-Year Return

IMCC
99.97%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY24
Revenue 13.34M
Earnings -1.01M
Profit Margin -7.58%

Q1

FY24

Q2

FY24

Q3

FY24

Q4

FY24

-5M
0
5M
10M
-40.0%
-30.0%
-20.0%
-10.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -39.13%

  • Return on Assets (ttm)

    -18.57%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    45.8M

  • Net Income Avi to Common (ttm)

    -17.92M

  • Diluted EPS (ttm)

    -76.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.62M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.13M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: